Related Experiment Video
Updated: Aug 7, 2026
14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Ligand-modified multifunctional liposome-based targeted delivery platform: a multimodal cancer combination therapy
Xuehong Zhang1, Yingjie Jiang2, Xing Duan3
1Department of Urology, Nanchang County People's Hospital. Nanchang 330200, Jiangxi, China.
Theranostics
|August 6, 2026
Summary
Ligand-modified liposomal drug delivery systems (LLDDS) offer enhanced cancer treatment by precisely targeting tumors. These advanced systems improve drug efficacy and reduce side effects, overcoming limitations of traditional therapies.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapeutics
Background:
- Combination cancer therapies outperform monotherapies but face challenges in precise drug delivery.
- Nanocarrier technology is advancing, leading to sophisticated drug delivery systems.
- Liposomes offer advantages for drug delivery, but targeted modification is key.
Purpose of the Study:
- To review the development and advancements of ligand-modified liposomal drug delivery systems (LLDDS).
- To highlight LLDDS's potential in enhancing anticancer efficacy and reducing toxicity.
- To examine the clinical translation challenges and future prospects of LLDDS.
Main Methods:
- Review of existing literature on liposomes and ligand modification strategies.
- Analysis of surface-engineered nanocarriers, specifically LLDDS.
- Discussion of multifunctional LLDDS for integrated cancer therapy.
Main Results:
- LLDDS integrate ligand targeting with liposome advantages for improved tumor delivery.
- These systems demonstrate enhanced pharmacokinetics, biodistribution, and anticancer efficacy.
- LLDDS enable multifunctional integration for diverse therapeutic strategies.
Conclusions:
- LLDDS represent a promising advancement in targeted cancer therapy.
- Further research and development are needed to overcome clinical translation hurdles.
- LLDDS hold significant potential for improving integrated cancer treatment approaches.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...